ARCHIVES

Recompetition of $1.9 Mil. Primate Contract Approved

This article is from The Cancer Letter archive.

Vol. 11 No. 44 | November 15, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

Murphy Withdraws From SU Position

October 17, 1986

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011